NYSE · CLConsumer StaplesCosmetics & Personal Care

Colgate-Palmolive Company (CL)

$98.76+3.28%
Close Nov 4, 2026 · split-adjusted
Nov 3, 2026$95.88▲ 27.87% in range
Nov 3, 2025Low $74.98 · High $99.14Nov 3, 2026
What changed · written from our data
As of Nov 4, 2026

Colgate-Palmolive closed at $98.76 on Nov 4, up 3.28%, 0.4% below its 52-week closing high. Volume of 5.7M shares was 1.17× its 20-day average (close to normal).

Split-adjusted performance: +13.2% over one month, +12.0% over six months, +31.7% over one year.

In the quarter ended Sep 30, 2026, revenue was $5.37B, up 4.6% from a year earlier, with a net margin of 14.0%.

Short interest was 17.4M shares at the Oct 15 settlement, down 27.6% from the prior report (2.2% of float, 3.5 days to cover).

Market cap$78.51B794.9M shares
Revenue · quarter$5.37B+4.6% YoY
Diluted EPS$0.94+3.3% YoY
P/E · TTM38.2×P/S 3.7×
Net margin14.0%Gross 60.2%
Dividend yield2.15%$0.53 last paid
52-week range74.98 – 99.14−0.4% from high
Volume5.7M1.17× 20-day avg
Volatility · 60d22.5%Annualised
Short % of float2.2%3.5 days to cover
Net cash-$6.19BCash $1.53B
Next earnings—Not scheduled
Split-adjusted performance
1W +7.7%1M +13.2%3M +6.2%6M +12.0%YTD +25.0%1Y +31.7%3Y +33.7%5Y +30.1%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Cosmetics & Personal Care

Percentile among 12 companies (100 = best)

6-month momentum55
Revenue growth56
Net margin90
Value (low P/E)—
Size100

Industry medians: 6-month return +7.1%, revenue growth +3.4%, net margin 6.3%, P/E 30.9×.

Short interest

Details →
Shares short17.4M−27.6% vs prior
Days to cover3.5Settled Oct 15
% of float2.2%
Short vol. 10d55.3%of daily volume

Closest peers by size in Cosmetics & Personal Care

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
CLColgate-Palmolive$98.76+3.28%+12.0%+4.6%14.0%38.2$78.51B
ELThe Estee Lauder Companies$112.04+6.31%+29.3%+6.7%6.3%110.3$40.59BCompare
ELFe.l.f. Beauty$113.63+1.91%+85.0%+35.5%13.9%112.5$6.71BCompare
IPARInterparfums$123.57+5.53%+30.3%+2.1%8.9%23.6$3.96BCompare
COTYCOTY$3.47+5.47%+30.9%+1.3%−11.4%—$3.06BCompare
EPCEdgewell Personal Care$29.66+6.19%+32.5%+1.7%2.4%—$1.37BCompare
SLSNSolesence$0.9140+6.76%−27.5%−24.7%−1.0%—$64.6MCompare
AXILAXIL Brands$5.60−2.78%−17.4%−11.2%6.9%13.7$38.2MCompare
UGUnited-Guardian$6.86+0.44%+2.2%+9.5%23.4%12.8$31.5MCompare

Quick answers

What does Colgate-Palmolive do?
Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries.
What is CL's market cap?
$78.51B, based on the Nov 4 close of $98.76.
What is CL's P/E ratio?
38.2× trailing-twelve-month earnings of $2.05B.
Does Colgate-Palmolive pay a dividend?
Yes. The latest regular dividend was $0.53 per share (ex-date Oct 20), an annualised yield of 2.15%.
How much of CL is sold short?
17.4M shares, 2.2% of float, as of Oct 15, 2026.
What sector is CL in?
Consumer Staples, in the Cosmetics & Personal Care industry.

About Colgate-Palmolive

Since its founding in 1806, Colgate-Palmolive has grown into a leading player in the household and personal care industry. In addition to its namesake oral care line (which accounts for more than 40% of its total sales), the firm manufactures shampoos, shower gels, deodorants, and home care products sold in over 200 countries. International sales account for about 70% of its total business, including nearly half from emerging regions. It also owns the specialty pet food maker Hill's (which accounts for almost one-fourth of its sales), where the majority of its products are sold through veterinarians and specialty pet retailers.

HQ: New York, NY33,600 employeesListed Jan 9, 1951colgatepalmolive.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology